Cargando…

Prognostic differences in grading and metastatic lymph node pattern in patients with small bowel neuroendocrine tumors

PURPOSE: Neuroendocrine tumors of the small intestine (si-NET) describe a heterogenous group of neoplasms. Based on the Ki67 proliferation index si-NET are divided into G1 (Ki67 < 2%), G2 (Ki67 3–20%) and rarely G3 (Ki67 > 20%) tumors. However, few studies evaluate the impact of tumor grading...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reinhard, Lisa, Mogl, Martina T., Benz, Fabian, Dukaczewska, Agata, Butz, Frederike, Dobrindt, Eva Maria, Tacke, Frank, Pratschke, Johann, Goretzki, Peter E., Jann, Henning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277262/ https://www.ncbi.nlm.nih.gov/pubmed/37332044 http://dx.doi.org/10.1007/s00423-023-02956-8

Ejemplares similares

Surgical Approach to Liver Metastases in GEP-NET in a Tertiary Reference Center
por: Butz, Frederike, et al.
Publicado: (2023)

Insulinoma in pregnancy (a case presentation and systematic review of the literature)
por: Dobrindt, Eva M, et al.
Publicado: (2021)

A rare case of a patient with a high grade neuroendocrine tumor developing neutropenic sepsis after receiving PRRT combined with Capecitabine or Temozolomide: A case report
por: Özdirik, Burcin, et al.
Publicado: (2021)

Hyperkalemia Following Parathyroidectomy in Patients with Renal Hyperparathyroidism—New Thresholds for Urgent Perioperative Dialysis
por: Bures, Claudia, et al.
Publicado: (2022)

A case report of an excellent response to interferon- α in a patient with functional metastasized neuroendocrine tumor refractory to other treatments
por: Özdirik, Burcin, et al.
Publicado: (2020)

The challenge to differentiate between sarcoma or adrenal carcinoma—an observational study
por: Dobrindt, Eva M, et al.
Publicado: (2021)

Surgery for Renal Hyperparathyroidism in the Era of Cinacalcet: A Single-Center Experience
por: Mogl, M. T., et al.
Publicado: (2020)

Association of lymph node metastases, grade and extent of mesenteric lymph node dissection in locoregional small intestinal neuroendocrine tumors with recurrence‐free survival
por: Daskalakis, Kosmas, et al.
Publicado: (2022)

Serum levels of miR-223 but not miR-21 are decreased in patients with neuroendocrine tumors
por: Hellberg, Teresa, et al.
Publicado: (2020)

Inflammatory Cytokines Associated with Diagnosis, Tumor Grade and Prognosis in Patients with Neuroendocrine Tumors
por: Geisler, Lukas, et al.
Publicado: (2022)

Prognostic Performance of Different Lymph Node Staging Systems in Patients With Small Bowel Neuroendocrine Tumors
por: Jiang, Sujing, et al.
Publicado: (2020)

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations Are Elevated in Patients with Neuroendocrine Malignancies
por: Özdirik, Burcin, et al.
Publicado: (2020)

Adrenal Metastasis of Hepatocellular Carcinoma in Patients following Liver Resection or Liver Transplantation: Experience from a Tertiary Referral Center
por: Teegen, Eva M., et al.
Publicado: (2018)

Lymph Node Diameter as a Predictor of Lymph Node Metastasis in Patients with Colorectal Neuroendocrine Neoplasms
por: Fujikawa, Kaoru, et al.
Publicado: (2022)

Analysis of miR-29 Serum Levels in Patients with Neuroendocrine Tumors—Results from an Exploratory Study
por: Özdirik, Burcin, et al.
Publicado: (2020)

PD-L1 – inhibitors in neuroendocrine neoplasia: Results from a real-life study
por: Özdirik, Burcin, et al.
Publicado: (2021)

A small, low-grade rectal neuroendocrine tumor with lateral pelvic lymph node metastasis: a case report
por: Shin, Seonhui, et al.
Publicado: (2022)

Tumor grade 2 as the independent predictor for lymph node metastasis in 10–20 mm sized rectal neuroendocrine tumor
por: Park, Byung-Soo, et al.
Publicado: (2021)

Elevated Flt3L Predicts Long-Term Survival in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms
por: Detjen, Katharina M., et al.
Publicado: (2021)

Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future
por: Stueven, Anna Kathrin, et al.
Publicado: (2019)

Primary Neuroendocrine Neoplasms of the Breast: Case Series and Literature Review
por: Özdirik, Burcin, et al.
Publicado: (2020)

Distribution of gastrointestinal neuroendocrine tumors in Europe: results from a retrospective cross-sectional study
por: Loosen, Sven H., et al.
Publicado: (2022)

Lymph node ratio, but not the total number of examined lymph nodes or lymph node metastasis, is a predictor of overall survival for pancreatic neuroendocrine neoplasms after surgical resection
por: Liu, Peng, et al.
Publicado: (2017)

A tailored approach in lymph node-positive perihilar cholangiocarcinoma
por: Benzing, Christian, et al.
Publicado: (2021)

Osteopontin is a prognostic circulating biomarker in patients with neuroendocrine neoplasms
por: Kidess, Evelyn, et al.
Publicado: (2023)

Risk factors for lymph node metastasis and prognosis in colorectal neuroendocrine tumours
por: Zheng, Xiuli, et al.
Publicado: (2022)

Risk factors for lymph node metastasis in patients with pancreatic neuroendocrine neoplasms
por: Nakao, Yosuke, et al.
Publicado: (2022)

Significance of the Surgical Treatment with Lymph Node Dissection for Neuroendocrine Tumors of Thymus
por: Ose, Naoko, et al.
Publicado: (2023)

Clinicopathological features and lymph node and distant metastasis patterns in patients with gastroenteropancreatic mixed neuroendocrine‐non‐neuroendocrine neoplasm
por: Zhang, Panpan, et al.
Publicado: (2021)

Malignant neuroendocrine tumour of the appendix in childhood with loco-regional lymph node invasion
por: Lyons, Rebecca F, et al.
Publicado: (2015)

Impact and Clinical Predictors of Lymph Node Metastases in Nonfunctional Pancreatic Neuroendocrine Tumors
por: Jiang, Yu, et al.
Publicado: (2015)

Synchronous Peripancreatic Lymph Node Gastrinoma and Gastric Neuroendocrine Tumor Type 2
por: Lee, Hee Woo, et al.
Publicado: (2016)

Difficulty of predicting lymph node metastasis on CT in patients with rectal neuroendocrine tumors
por: Ushigome, Hajime, et al.
Publicado: (2019)

Risk Factors of Lymph Node Metastasis in Patients with Pancreatic Neuroendocrine Tumors (PNETs)
por: Wang, Zhe, et al.
Publicado: (2020)

Risk Factors for Lymph Node Metastasis and Survival Outcomes in Colorectal Neuroendocrine Tumors
por: Wu, Zijian, et al.
Publicado: (2020)

Evaluation of Risk Factors for Distant and Lymph Node Metastasis of Pancreatic Neuroendocrine Tumors
por: Molasy, Bartosz, et al.
Publicado: (2022)

A Lymph Node Ratio Model for Prognosis of Patients with Pancreatic Neuroendocrine Tumors
por: Osher, Esther, et al.
Publicado: (2023)

The Role of miRNA in the Pathophysiology of Neuroendocrine Tumors
por: Geisler, Lukas, et al.
Publicado: (2021)

Sentinel Lymph Node Mapping in High-Grade Endometrial Cancer
por: Salman, Lina, et al.
Publicado: (2022)

The Role of Alternative Lymph Node Classification Systems in Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NEN): Superiority of a LODDS Scheme Over N Category in Pancreatic NEN (pNEN)
por: Krieg, Sarah, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6bre38ke1abdek7ku1c649pn3e